【摘要】目的评价健脾益气法治疗中晚期原发性肝癌的临床疗效。
Abstract】 Objective To evaluate the efficiacy of Jianpiyiqi of traditional chinese medicine in the treatment of middle stage or advanced hepatocellular carcinoma.
目的分析TACE、PEI、PVC三介入联合治疗中晚期原发性肝癌的临床疗效。
Objective To explore the clinical efficacies of TACE, PEI, PVC, for advanced Liver cancer.
目的：观察中医综合治疗方案治疗原发性中晚期肝癌的疗效。
Objective: to observe the effects of complex treatment with traditional Chinese medicine on advanced primary hepatocarcinoma.
结论中晚期不能切除的原发性肝癌使用肝动脉、门静脉双重插管灌注化疗，可以改善临床症状、延长存活期。
Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.
目的探讨肝动脉、门静脉双重插管区域灌注化疗在中晚期不能切除原发性肝癌应用方法及临床疗效。
Objective To explore the curative effect of double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma.
目的探讨经肝动脉化疗栓塞(TACE)结合二期手术切除治疗原发性中晚期肝癌的价值。
Objective to evaluate the value of transhepatic arterial chemoembolization (TACE) combined with secondary hepatectomy for advanced primary liver carcinoma.
目的探讨经肝动脉化疗栓塞(TACE)结合二期手术切除治疗原发性中晚期肝癌的价值。
Objective to evaluate the value of transhepatic arterial chemoembolization (TACE) combined with secondary hepatectomy for advanced primary liver carcinoma.
应用推荐